Table 1. Demographic data, comorbidity and tumor types of study participants.
DEMOGRAPHIC DATA AND COMORBIDITY ALL STUDY PARTICIPANTS | ||||
---|---|---|---|---|
Cancer patients (n = 60) | Severely ill patients without known cancer (n = 51) | p-value | Healthy (n = 50) | |
Age, years (mean, SD) | 70.4 (12.4) | 76.7 (11.5) | 0.059 | 68.1 (7.7) |
Female (%) | 58 | 57 | 0.556 | 58 |
Comorbidity Index Score* | 3.3 ± 1.8 | 5.9 ± 2.1 | <0.001 | 0 |
Comorbidity: | ||||
Hypertension—no. (%) | 18 (30) | 34 (67) | <0.001 | 13 (26) |
Cerebrovascular disease—no. (%) | 10 (17) | 32 (63) | <0.001 | 0 |
Congestive heart disease- no. (%) | 6 (10) | 10 (20) | 0.122 | 0 |
Renal insufficiency- no. (%) | 7 (12) | 9 (18) | 0.266 | 0 |
Liver failure- no. (%) | 3 (5) | 11 (22) | 0.009 | 0 |
Diabetes mellitus type 1- no. (%) | 0 (0) | 11 (22) | 0.209 | 0 |
Diabetes mellitus type 2- no. (%) | 9 (15) | 13 (25) | 0.127 | 0 |
Chronic pulmonary disease- no. (%) | 4 (7) | 9 (18) | 0.067 | 0 |
Dementia- no. (%) | 0 (0) | 8 (16) | 0.001 | 0 |
Acute infection- no. (%) | 6 (10) | 7 (14) | 0.376 | 0 |
TUMOR TYPES CANCER PATIENTS | ||||
Adenocarcinomas: | No. (%) | Localized (no.) | Spread (no.) | |
Breast | 10 (17) | 0 | 10 | |
Colorectal | 11 (18) | 0 | 11 | |
Stomach | 2 (3) | 0 | 2 | |
Biliary tract | 2 (3) | 0 | 2 | |
Peritoneum | 2 (3) | 1 | 1 | |
Lung | 6 (10) | 1 | 5 | |
Prostate | 5 (8) | 0 | 5 | |
Gynecological | 4 (7) | 0 | 4 | |
Pancreas | 2 (3) | 0 | 2 | |
Unknown origin | 2 (3) | 0 | 2 | |
Squamous cell carcinomas: | ||||
Esophagus | 1 (2) | 0 | 1 | |
Lung | 1 (2) | 0 | 1 | |
Gingival | 1 (2) | 0 | 1 | |
Melanoma | 3 (5) | 0 | 3 | |
Glioblastoma | 3 (5) | 1 | 2 | |
Other** | 5 (8) | 3 | 2 |
SD, standard deviation
* Comorbidity Index Score calculated from the Charlson Comorbidity Index (CCI).
** Other primary tumor types were neuroendocrine (N = 1), sarcoma (N = 1), liposarcoma, (N = 1), lymphoma (N = 1) and acute myeloid leukemia (N = 1). Fisher's exact test for categorical data; Mann-Whitney U test for continuous data.